Abstract:<p>Stage 1 hypertension, newly defined by the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guideline, has been the subject of significant interest globally. This study aims to assess the impact of the new blood pressure (BP) stratum on subsequent subclinical cardiovascular outcomes in low‐risk young adults. This longitudinal study consisted of 1020 young adults (47.7% female; ages 18–23 years) free of cardiovascular disease from the Hanzhong Adolescent Hypertension Cohort with up to 25‐year follow‐up since 1992–1995. Outcomes were available through June 2017. Young adults with stage 1 hypertension accounted for 23.7% of the cohort. When it comes to middle adulthood, subjects with early life stage 1 hypertension were more likely to experience BP progression, and they had a 1.61‐fold increased risk of high‐risk brachial‐ankle pulse wave velocity (baPWV) and a 2.92‐fold risk of left ventricular hypertrophy (LVH) comparing with their normotensive counterparts. Among participants without any active treatment in midlife, the risk associated with stage 1 hypertension for BP progression was 2.25 (95% confidence interval [CI] = 1.41–3.59), high‐risk baPWV was 1.58 (95% CI = 1.09–2.79), LVH was 2.75 (95% CI = 1.16–6.48), and subclinical renal damage (SRD) was 1.69 (95% CI = 1.02–2.82) compared with the normal BP group. Overall, young adults with stage 1 hypertension had significantly higher risks for midlife subclinical cardiovascular outcomes than normotensive subjects. BP management targeting low‐risk young adults is of importance from both clinical and public health perspectives.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the impact of the newly defined blood pressure (BP) classification in the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines on the long - term subclinical cardiovascular outcomes of low - risk young people. Specifically, the study aims to explore the association between stage 1 hypertension in early adulthood and subclinical cardiovascular outcomes in middle - aged people, such as hypertension defined traditionally, high - risk ankle - brachial pulse wave velocity (baPWV), left ventricular hypertrophy (LVH) and subclinical renal damage (SRD). ### Research Background - **Hypertension**: A global public health crisis, it is one of the most common preventable disease risk factors, leading to multiple organ damage and increasing the risk of cardiovascular diseases. - **Young Population**: Although the harm of hypertension is well - known, most studies have focused on high - risk or elderly populations, and the evidence for young populations (traditionally considered as low - risk groups) is still limited. - **2017 Guideline Update**: The ACC/AHA recommends lowering the threshold for hypertension from 140/90 mmHg to 130/80 mmHg, and this change has a direct impact on the estimation of the association between blood pressure classification and cardiovascular diseases and their subclinical risks. ### Research Objectives - **Evaluate New BP Classification**: Using data from the Hanzhong Adolescent Hypertension Cohort, study the risk of subclinical cardiovascular outcomes in young Chinese populations in the BP classification in the 2017 ACC/AHA guidelines. - **Long - term Follow - up**: Through a 25 - year follow - up, evaluate the impact of stage 1 hypertension in early adulthood on subclinical cardiovascular outcomes in middle - aged people. ### Main Findings - **Stage 1 Hypertension**: Stage 1 hypertension in early adulthood significantly increases the risk of hypertension, high - risk baPWV, LVH and SRD in middle - aged people. - **Risk Quantification**: - The risk of stage 1 hypertension patients progressing to a higher BP category is 2.21 times that of the normal BP group (OR = 2.21, 95% CI = 1.45–3.34). - The risk of high - risk baPWV in stage 1 hypertension patients is 1.61 times that of the normal BP group (OR = 1.61, 95% CI = 1.07–2.70). - The risk of LVH in stage 1 hypertension patients is 2.92 times that of the normal BP group (OR = 2.92, 95% CI = 1.35–6.35). - The risk of SRD in stage 1 hypertension patients is 1.69 times that of the normal BP group (OR = 1.69, 95% CI = 1.02–2.82). ### Conclusions - **Importance of Early BP Control**: The research results emphasize the importance of early BP control in young Chinese populations to prevent the progression of hypertension and protect organs from damage, thereby effectively and economically reducing the risk of cardiovascular diseases. - **Policy Recommendations**: It is necessary to strengthen health education, early detection and intervention measures to increase hypertension awareness, treatment rate and control rate in young populations. ### Limitations - **Influence of Baseline BP Level**: Due to the influence of the baseline BP level, the OR may be underestimated. - **Single - center Study**: The research data comes from a single region and may not fully represent the national situation. Overall, this study provides important evidence support for the application of the 2017 ACC/AHA guidelines in young populations.

Blood pressure and long‐term subclinical cardiovascular outcomes in low‐risk young adults: Insights from Hanzhong adolescent hypertension cohort

Long-Term Cardiovascular Risk Associated with Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.

Baseline and Longitudinal Change in Blood Pressure and Mortality in a Chinese Cohort

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

Stage 1 Hypertension Defined by the 2017 ACC/AHA Guideline Predicts Future Cardiovascular Events in Elderly Chinese Individuals.

The predictive value of repeated blood pressure measurements in childhood for cardiovascular risk in adults: the Hanzhong Adolescent Hypertension Study

Isolated Systolic or Diastolic Hypertension and Mortality Risk in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline: a Longitudinal Cohort Study

EARLY LIFE BLOOD PRESSURE TRAJECTORIES AND SUBCLINICAL VASCULAR DAMAGE IN MIDLIFE: A 30-YEAR PROSPECTIVE COHORT STUDY

Hypertension Defined by 2017 ACC/AHA Guideline, Ideal Cardiovascular Health Metrics, and Risk of Cardiovascular Disease: A Nationwide Prospective Cohort Study

Risk Of Progression To Hypertension Across Baseline Blood Pressure In Nonhypertensive Participants Among Rural Chinese Adults: A Prospective Study

Increased Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a Low-Risk Cohort

Blood pressure categories defined by the 2017 ACC/AHA guideline and all-cause mortality: a national cohort study in China and meta-analysis

Factors influencing normal blood pressure maintenance in young adults

Increased Adverse Pregnancy Outcomes Associated with Stage 1 Hypertension in a Low-Risk Cohort: Evidence from 47 874 Cases.

Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis

Associations of Blood Pressure Categories According to the 2017 American College of Cardiology/American Heart Association Hypertension Guideline and Long-Term Blood Pressure Change with Incident Cardiovascular Disease in Middle-Aged and Elderly Chinese: the Dongfeng-Tongji Cohort Study

Associations of Blood Pressure Categories Defined by 2017 ACC/AHA Guidelines with Mortality in China: Pooled Results from Three Prospective Cohorts

Modifiable Factors of 20-Year Blood Pressure Trajectories among Normotensives and Their Associations with Hypertension : a Prospective Study.

Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults

[Effect of Blood Pressure Status Changes from Childhood to Adulthood on Hypertension Related Cardiac-Renal Function in Adulthood].

Predictive Role of Child-To-Adult Blood Pressure Trajectories for Incident Metabolic Syndrome: 30-Year Hanzhong Adolescent Hypertension Study